Stable formulation for parenteral administration of Tapentadol
The invention relates to an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof; wherein the concentration of Tapentadol is greater than 8.00 mg/mL, based on the weight of Tapentadol free base and based on the total volu...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
14.03.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!